Literature DB >> 12850205

Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice.

André Talvani1, Gilcinea Santana, Lucíola S Barcelos, Satoshi Ishii, Takao Shimizu, Alvaro J Romanha, João S Silva, Milena B P Soares, Mauro M Teixeira.   

Abstract

The generation of an inflammatory response driven by Trypanosoma cruzi or its subproducts appears to be essential for tissue injury and disease pathogenesis. However, this inflammatory response is also relevant in the control of T. cruzi replication. The lipid mediator platelet-activating factor (PAF) has been implicated in a number of pathological conditions characterized by tissue inflammation. In the present study, we aimed at evaluating the role of PAF during T. cruzi infection by using mice that were genetically deficient in the PAF receptor. We observed that infected hearts of PAFR(-/-) mice had an increased number of parasite nests, associated with a more intense inflammatory infiltrate. This was associated with greater parasitemia and lethality. When wild-type and PAFR(-/-) mice were compared, there were no marked changes in the kinetics of the expression of MCP-1, RANTES, IFN-gamma and TNF-alpha in heart tissue of infected animals. Moreover, serum concentrations of TNF-alpha, nitrate and parasite-specific IgM were similar in both groups of mice. In vitro, macrophages from PAFR(-/-) animals did not phagocytose trypomastigote forms when activated with PAF, leukotriene B(4) or MCP-1 and produced less nitric oxide when infected and activated with IFN-gamma. These results are consistent with the hypothesis that endogenous synthesis of PAF and activation of PAF receptors control T. cruzi replication in mice in great part via facilitation of the uptake of the parasite and consequent activation of macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850205     DOI: 10.1016/s1286-4579(03)00146-1

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  9 in total

Review 1.  The vasculature in chagas disease.

Authors:  Cibele M Prado; Linda A Jelicks; Louis M Weiss; Stephen M Factor; Herbert B Tanowitz; Marcos A Rossi
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

2.  Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection.

Authors:  Danielle G Souza; Caio T Fagundes; Lirlandia P Sousa; Flavio A Amaral; Rafael S Souza; Adriano L Souza; Erna G Kroon; Daniela Sachs; Fernando Q Cunha; Eugenij Bukin; Alena Atrasheuskaya; George Ignatyev; Mauro M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-30       Impact factor: 11.205

3.  Mice with Genetic Deletion of Group VIA Phospholipase A2β Exhibit Impaired Macrophage Function and Increased Parasite Load in Trypanosoma cruzi-Induced Myocarditis.

Authors:  Janhavi Sharma; Jennifer R Blase; Daniel F Hoft; John O Marentette; John Turk; Jane McHowat
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

4.  Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Authors:  Kent Doi; Koji Okamoto; Kousuke Negishi; Yoshifumi Suzuki; Akihide Nakao; Toshiro Fujita; Akiko Toda; Takehiko Yokomizo; Yoshihiro Kita; Yasuyuki Kihara; Satoshi Ishii; Takao Shimizu; Eisei Noiri
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

5.  The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.

Authors:  Janhavi Sharma; Christopher S Eickhoff; Daniel F Hoft; David A Ford; Richard W Gross; Jane McHowat
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

6.  Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.

Authors:  Han-A Kim; So-Hee Kim; Hyun-Mi Ko; Jung-Hwa Choi; Kyoung-Jin Kim; Sin-Hye Oh; Kyoung-Oh Cho; Il-Whan Choi; Suhn-Young Im
Journal:  Immunology       Date:  2008-04-04       Impact factor: 7.397

7.  A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection.

Authors:  Christian M Probst; Rodrigo A Silva; Juliana P B Menezes; Tais F Almeida; Ivana N Gomes; Andréia C Dallabona; Luiz S Ozaki; Gregory A Buck; Daniela P Pavoni; Marco A Krieger; Patrícia S T Veras
Journal:  BMC Microbiol       Date:  2012-02-09       Impact factor: 3.605

8.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy.

Authors:  Christophe Chevillard; João Paulo Silva Nunes; Amanda Farage Frade; Rafael Ribeiro Almeida; Ramendra Pati Pandey; Marilda Savóia Nascimento; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2018-12-03       Impact factor: 7.561

9.  Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.

Authors:  Felipe Gazos-Lopes; Mauricio M Oliveira; Lucas V B Hoelz; Danielle P Vieira; Alexandre F Marques; Ernesto S Nakayasu; Marta T Gomes; Nasim G Salloum; Pedro G Pascutti; Thaïs Souto-Padrón; Robson Q Monteiro; Angela H Lopes; Igor C Almeida
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.